STRATA Skin Sciences Profit Margin

The latest profit margin for SSKN is -20.4% as of December 2025. That compares with -30.05% in the prior-year period — up 32.1% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside STRATA Skin Sciences's historical trend and sector peers before judging valuation or financial health.

Over the past year, SSKN's profit margin moved from -30.05% to -20.4% — a 32.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in STRATA Skin Sciences's valuation or profitability profile.

Against Healthcare companies, SSKN currently prints -20.4% for profit margin, while the sector average sits near 15.58%. That is roughly 230.9% below the sector mean. Large gaps often invite a closer look at STRATA Skin Sciences's growth, margins, and balance sheet.

Profit Margin shows how effectively STRATA Skin Sciences converts resources into returns. At -20.4%, SSKN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -30.05% in the prior-year period — up 32.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SSKN's profit margin (-20.4%), review year-over-year change from -30.05%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.